Last reviewed: June 27, 2026
Last updated: June 27, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Medications in the GLP-1 receptor agonist class have become a cornerstone of modern weight loss therapy, with clinical trials showing an average weight reduction of 15–22% over 68 weeks. These drugs work by mimicking a natural hormone that signals fullness to your brain and slows stomach emptying. PlexusDx brings this proven therapy to all 50 states through compounded formulations prepared by licensed 503A pharmacies.
How GLP-1 Weight Loss Medications Work
GLP-1 receptor agonists activate receptors in your brain, pancreas, and gut to reduce hunger signals and increase feelings of satisfaction after eating smaller portions. This mechanism also improves how your body regulates blood sugar levels, which can help prevent weight regain over time. The medication slows the rate at which food moves through your stomach, meaning you feel fuller for longer after meals.
Unlike older weight loss drugs that primarily stimulated metabolism or blocked fat absorption, GLP-1 therapies address the root biological pathways controlling appetite and satiety. Research shows this approach leads to more sustainable weight loss because it changes how your brain perceives hunger rather than forcing restriction through side effects. Studies consistently demonstrate that patients on GLP-1 therapy maintain weight loss better than those using diet and exercise alone.
Semaglutide vs. Other GLP-1 Medications
Semaglutide is a long-acting GLP-1 agonist designed to be dosed once weekly, making it more convenient than daily medications. It has the longest clinical track record, with over a decade of use in diabetes management before weight loss applications became standard. The medication reaches peak concentration about 1–3 days after injection, providing steady appetite suppression throughout the week.
Tirzepatide, by contrast, activates both GLP-1 and GIP receptors simultaneously, potentially offering greater weight loss in some patients—though individual response varies widely. PlexusDx offers both semaglutide injections starting at $149 monthly and tirzepatide injections starting at $249 monthly, allowing personalization based on your unique peptide pathway response. Your dose may need to go up. Your price won't.
Clinical Evidence and Weight Loss Results
The STEP trials, which enrolled over 4,500 people with obesity, found that semaglutide 2.4 mg weekly produced an average weight loss of 14.9% of body weight over 68 weeks, compared to 2.4% with placebo. When combined with lifestyle modifications, patients achieved even greater results, with some studies showing weight reductions exceeding 20%. These outcomes held steady during extended follow-up periods, suggesting that the medication helps maintain rather than temporarily reduce weight.
Beyond weight loss, GLP-1 medications improve cardiovascular risk factors including blood pressure, triglycerides, and inflammation markers. Patients also report improvements in energy levels, mobility, and quality of life once they reach a stable dose. The consistency of these benefits across diverse populations supports their use as a foundational tool in precision weight management programs like those offered by PlexusDx.
Compounded Semaglutide: Access and Affordability
PlexusDx provides compounded semaglutide injections prepared by licensed 503A compounding pharmacies, ensuring quality and safety while bypassing high brand-name costs. The medication is available in all 50 states without requiring insurance, membership fees, or prior authorization—just a consultation with PlexusDx clinicians. Patients can use HSA or FSA accounts to cover the cost, adding another layer of affordability.
Starting at $149 monthly for compounded semaglutide injection, PlexusDx pricing remains flat across three commitment tiers, meaning your dose may increase during treatment but your monthly cost won't. The Precision Peptide Genetic Test ($99 add-on after first month) maps 14 peptide pathways and 150+ genetic insights to predict which formulation—semaglutide, tirzepatide, or the dual GLP-Squared compound—will deliver the best response for your biology. This precision approach reduces trial-and-error dosing and accelerates your path to a stable, effective dose.
Common Side Effects and What to Expect
Nausea is the most frequently reported side effect, especially during dose escalation, occurring in 20–40% of patients in clinical trials. Other common effects include vomiting, constipation, and reduced appetite—which, while uncomfortable early on, often diminish as your body adapts over 2–4 weeks. Severe adverse events are rare; most patients find that side effects are manageable and outweighed by weight loss and improved metabolic health.
Starting with the lowest effective dose and titrating slowly minimizes nausea risk. PlexusDx clinicians work with you during dose adjustment phases to manage symptoms through dietary modifications, hydration, and anti-nausea strategies. If one GLP-1 formulation causes intolerable side effects, switching to oral semaglutide, tirzepatide, or the microdose GLP-1 protocol (starting at $129/month) provides alternatives that may be better tolerated while preserving therapeutic benefit.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded semaglutide as safe as the brand-name version?
Yes. PlexusDx sources all compounded medications from licensed 503A compounding pharmacies, which follow FDA manufacturing standards and quality controls. These facilities compound semaglutide to the same pharmaceutical grade as brand names, without the markup. Third-party testing and pharmacist oversight ensure purity and potency in every batch.
How much weight can I realistically lose with semaglutide?
Clinical trials show average weight loss of 14–22% of body weight over 68 weeks when combined with lifestyle changes. Individual results vary based on genetics, adherence, diet quality, and exercise—which is why PlexusDx offers the Precision Peptide Genetic Test to predict your likely response and optimize your formulation before starting treatment.
Do I need insurance to use PlexusDx semaglutide?
No. PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorization. Compounded semaglutide starts at $149 monthly and is HSA/FSA eligible, making it accessible to uninsured and self-pay patients. Most patients find the monthly cost far lower than brand-name alternatives.
What happens if I stop taking semaglutide?
Weight typically returns gradually over several months if diet and exercise do not change, though not always to baseline. This is why PlexusDx emphasizes lifestyle integration alongside medication—the drug is most effective as part of a sustained behavior change program. Some patients maintain weight loss long-term even after stopping, while others restart therapy seasonally or as needed.
Can the Precision Peptide Genetic Test predict if semaglutide will work for me?
The Precision Peptide Genetic Test analyzes key variants in GLP1R, GIPR, FTO, and MC4R genes across 14 peptide pathways to predict which formulation—semaglutide, tirzepatide, or dual GLP-Squared—will produce the strongest response in your body. This $99 test (added after your first month) reduces guesswork and helps PlexusDx clinicians optimize your regimen for maximum efficacy and tolerability.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What to Expect After Your First Ozempic Shot
Managing Polycystic Ovary Syndrome: How Can Ozempic Help PCOS Symptoms and Weight Loss?